Filing Flows › EyePoint (EYPT) › R&D spending
EyePoint (EYPT) R&D spending by quarter
EyePoint's R&D spending was $83.6M in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 7 quarters it ranged from $43.4M (Q4 2024) to $83.6M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $83.6M | +16% | +51% |
| Q1 2026 | $72.1M | +22% | +23% |
| Q4 2025 | $59.2M | +24% | +37% |
| Q3 2025 | $47.8M | -14% | — |
| Q2 2025 | $55.5M | -5% | — |
| Q1 2025 | $58.6M | +35% | — |
| Q4 2024 | $43.4M | — | — |
Q2 2026 at a glance
EyePoint, Q2 2026: revenue $507K (-90% year over year), net loss $94.5M, operating cash flow −$62.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is EyePoint's R&D spending?
EyePoint's R&D spending was $83.6M in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has EyePoint's R&D spending changed?
Over the last 7 quarters it ranged from $43.4M (Q4 2024) to $83.6M (Q2 2026).